Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer

INTRODUCTION: To investigate the factors that affect the choice of 5-fluorouracil (5-FU) or its oral alternative, capecitabine, as first-line treatment in patients with colorectal cancer (CRC). METHODS: Patients treated with 5-FU or capecitabine for CRC between January 1, 2011 and December 31, 2013...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloem, Lourens T., De Abreu Lourenço, Richard, Chin, Melvin, Ly, Brett, Haas, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315063/
https://www.ncbi.nlm.nih.gov/pubmed/28261643
http://dx.doi.org/10.1007/s40487-016-0020-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315063/
https://www.ncbi.nlm.nih.gov/pubmed/28261643
http://dx.doi.org/10.1007/s40487-016-0020-4

Ejemplares similares